KMT2D deficiency confers a therapeutic vulnerability to glycolytic and IGFR inhibitors in melanoma

Navya Murugesan, Mayinuer Maitituoheti

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'KMT2D deficiency confers a therapeutic vulnerability to glycolytic and IGFR inhibitors in melanoma'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Keyphrases